Comparison of therapeutic efficacy between fondaparinux and low molecular weight heparin for elderly patients with non-ST-segment elevation acute coronary syndromes
10.3760/cma.j.issn.1008-6315.2014.08.019
- VernacularTitle:磺达肝癸钠和低分子肝素在老年非ST段抬高的急性冠状动脉综合征患者中应用的比较
- Author:
Xiaojing BAO
;
Xiaoping BO
;
Chuangao YANG
;
Weihong LU
;
Zhenyu YANG
- Publication Type:Journal Article
- Keywords:
Non-ST-segment elevation acute coronary syndromes;
Fondaparinux;
Low molecular weight heparin
- From:
Clinical Medicine of China
2014;30(8):847-850
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the efficiency and safety of fondaparinux and low molecular weight heparin(LMWH) on the elder patients with non-ST-segnent elevation acute coronary syndromes (NSTE-ACS).Methods One hundred and forty patients over 75 years old with NSTE-ACS were randomly divided into treatment group(n =70) and control group (n =70).Patients in treatment group were given the conventional treatment combined with fondaparinux,and in control group were given the basis of conventional treatment combined with LMWH.The therapeutic efficacy,the cardiovascular events at 4 d,7 d and 30 d during the treatment and bleeding incidence rate were observed.Reslts There was no statistically significant difference between the treatment group and control group in the total effective rate (x2 =0.475,P ＞ 0.05.Meanwhile,no significant differences were found between the two groups in cardiovascular events at 4 d,7 d and 30 d (x2 =0.257,0.475 and 0.317,P ＞0.05).The incidence rate of bleeding in treatment group was obviously lower than that in control group and there was statistically significant difference (2.9％ vs.31.4％ ; x2 =20.115,P ＜0.01).Conclusion The effectiveness of fondaparinux used in elderly patients with non-ST-segment elevation acute coronary syndromes is similar with LMWH,but the incidence rate of bleeding is lower than LMWH.
